CLL T lymphocytes cultured under hypoxic conditions switch their metabolism toward glycolysis, with robust upregulation of glucose and lactate transporters and of lactate dehydrogenase (LDHA) and pyruvate kinase 2 (PKM2) [3]. The gene discussed is PKM; the disease is B-cell chronic lymphocytic leukemia.